New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;HMY;MRK;BAC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
December 15, 2014
08:30 EDTAAPLApple checks show solid brand recognition in China, says Jefferies
Subscribe for More Information
06:46 EDTAAPLApple could pay $450M if it loses e-book appeal, WSJ says
A report from yesterday explains that the Second U.S. Circuit Court of Appeals will begin considering Apple's appeal for a ruling that the company was engaged in illegal price-fixing over e-books, reports the Wall Street Journal. If Apple loses the appeal, the company could pay $450M, with most of it going to e-book customers, the Journal adds. Reference Link
05:39 EDTAAPLCirrus Logic upgraded to Overweight from Underweight at Barclays
Subscribe for More Information
December 12, 2014
16:33 EDTMRKStocks finish week lower amid steep decline in oil prices
Subscribe for More Information
16:00 EDTAAPLOptions Update; December 12, 2014
Subscribe for More Information
09:35 EDTAAPLActive equity options trading
Subscribe for More Information
08:43 EDTAAPLWal-Mart cuts prices on iPhone, BGR reports
Subscribe for More Information
07:21 EDTBACBofA/Merrill to hold a discussion
Subscribe for More Information
06:37 EDTAAPLApple online store begins accepting PayPal, Re/code reports
Subscribe for More Information
December 11, 2014
17:40 EDTAAPLPriceline becomes first online travel agency to integrate Apple PayApple
Subscribe for More Information
16:01 EDTAAPLOptions Update; December 11, 2014
Subscribe for More Information
14:50 EDTAAPLApple to start selling new iPads in China this week
Subscribe for More Information
13:11 EDTAAPLApple February volatility elevated at 28
Subscribe for More Information
10:17 EDTAAPLCiti upbeat on Google in face of pending Apple decision on Safari
Subscribe for More Information
10:17 EDTBACFINRA fines Barclays Capital, Citigroup Global Markets, others $43.5M total
FINRA announced that it has fined 10 firms a total of $43.5M for allowing their equity research analysts to solicit investment banking business and for offering favorable research coverage in connection with the 2010 planned initial public offering of Toys"R"Us. FINRA fined the following firms. Barclays Capital (BCS) - $5M; Citigroup Global Markets (C) $ 5M; Credit Suisse Securities (CS) $5M; Goldman, Sachs & Co. (CS) $5M; JP Morgan Securities LLC (JPM) $5M; Deutsche Bank Securities Inc. (DB) $4M; Merrill Lynch, Pierce, Fenner & Smith Inc. (BAC) $4M; Morgan Stanley & Co., LLC (MS) $4M; Wells Fargo Securities, LLC (WFC) $4M; Needham & Company LLC $2.5M. In addition, FINRA found that six of the 10 firms Barclays, Citigroup, Credit Suisse, Goldman Sachs, JP Morgan and Needham had inadequate supervisory procedures related to research analyst participation in investment banking pitches. Toys"R"Us and its sponsors offered each of the 10 firms various roles in the IPO but it eventually decided not to proceed with the offering. In settling this matter, the 10 firms neither admitted nor denied the charges, but consented to the entry of FINRA's findings.
09:37 EDTAAPLActive equity options trading
Subscribe for More Information
09:05 EDTAAPLTSMC reports November sales down 10.5% to $2.32B, DigiTimes reports
Subscribe for More Information
08:53 EDTAAPLBritain lays out details for proposed 25% 'Google Tax,' WSJ reports
U.S. technology giants such as Google (GOOGL, GOOG), Facebook (FB), Microsoft (MSFT) and Apple (AAPL) have come under fire in Britain for the relatively small corporate taxes they pay there and the U.K. government detailed plans for a new 25% tax on profits of multinational technology and other companies, reported The Wall Street Journal. Reference Link
08:46 EDTAAPLApple Watch mass production rumored to start in January, AppleInsider says
Subscribe for More Information
08:27 EDTMRKNewLink Genetics falls after Ebola vaccine trial suspended
Shares of NewLink Genetics (NLNK) are falling in pre-market trading after a clinical trial of the Ebola vaccine being developed by the company and partner Merck (MRK) was temporarily suspended as a precautionary measure after four patients complained of joint pains in their hands and feet, the University of Geneva Hospital said. The trials are scheduled to resume next month in up to 15 volunteers after checks to make sure that the joint pain symptoms were benign and temporary, the hospital added. Shares of NewLink are down 6.5% to $34.50 in early morning trading following the news, while Merck shares are indicated to open fractionally higher.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use